China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China · Delayed Price · Currency is CNY 15.68
-0.21 (-1.32%)
Jun 18, 2026, 3:04 PM CST
SHE:300294 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, SHE:300294 stock has a consensus rating of "Buy" and an average price target of ¥28.00. The average 1-year stock price forecast is 78.57% higher than the current stock price, while the lowest is ¥21.00 (+33.93%) and the highest is ¥35.00 (+123.21%).
Price Target: ¥28.00 (+78.57%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHE:300294 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 1 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 7 | 6 | 4 | 3 | 4 |
Financial Forecast
Revenue This Year
2.10B
from 2.06B
Increased by 2.21%
Revenue Next Year
2.21B
from 2.10B
Increased by 5.18%
EPS This Year
1.15
from -0.02
EPS Next Year
1.30
from 1.15
Increased by 13.04%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.3B | ||
| Avg | 2.1B | ||
| Low | 1.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.3% | ||
| Avg | 2.2% | ||
| Low | -8.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 1.15 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |